Alcon introduces expanded parameters for TOTAL30 for Astigmatism contact lens

News
Article

The lens is now available in a -2.75D cylinder offering, according to a news release.

Blurry vision of city Image credit: AdobeStock/dreamsgraphicdesign

Image credit: AdobeStock/dreamsgraphicdesign

Alcon has announced expanded parameters for TOTAL30 for Astigmatism, which is now available in a -2.75D cylinder offering. The contact lens is the first and only monthly replacement water gradient toric, according to a news release. The new parameters have been available since October 1, 2024.1

“From varying vision correction requirements to replacement schedule preferences, we are innovating to meet the diverse needs of today’s patients,” said Max Wolf, general manager and head of Vision Care and Contact Lenses at Alcon, in the release. “Because astigmatic patients disproportionately suffer from dryness and discomfort,2 the need for outstanding comfort and moisturization in a lens is paramount. With the release of extended parameters for TOTAL30 for Astigmatism in the US, we are delivering an exceptional offering from the TOTAL30 portfolio that fulfils those needs, allowing eye care professionals to reach more patients.

For the TOTAL30 lens family, the PRECISION BALANCE 8|4 lens design provides on-eye stability with a 95% first lens fit success rate. Additionally, the lenses feature Class 1 UV blocking against UVA and UVB rays, with blue-violet light filtration.1

“Patients with expanded parameters deserve innovation just like any other reusable lens wearer,” said Jessilin Quint, OD, MBA, MS, FAAO. “Previously, these patients had very few options and were forced to compromise on comfort, which is why I’m thrilled by this latest innovation from Alcon. Having expanded parameters for TOTAL30 for Astigmatism is a game changer for my patients because of how well the lens performs and how easy it is to order.”

Alcon also has informative materials and signage about TOTAL30 for Astigmatism available in various languages for eye care providers to take advantage of. For access to the materials, eye care providers can reach out to their Alcon representatives, and for more multilingual provider to patient resources, visit Alcon’s website.

References:
  1. Alcon reaffirms its commitment to astigmatic patients offering TOTAL30 for Astigmatism with expanded parameters. News release. Alcon. November 19, 2024. Accessed November 20, 2024.
  2. Young G, Sulley A, Hunt C. Prevalence of astigmatism in relation to soft contact lens fitting. Eye Contact Lens. 2011;37:20-25.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
© 2025 MJH Life Sciences

All rights reserved.